Table 1 Clinicopathologic characteristics of the study cases.

From: Clinicopathologic and molecular spectrum of testicular sex cord-stromal tumors not amenable to specific histopathologic subclassification

CASE

AGE (YRS1)

CYTO-MORPHOLOGY

TUMOR SIZE (CM)

MITOSES (PER 10 HPF)

PLEOMORPHISM

NECROSIS

LVI

CLINICAL COURSE

1

46

Biphasic

0.9

1

Absent

Absent

Absent

NED at 1 mo

2

41

Mixed

0.6

1

Absent

Absent

Absent

NED at 4 yrs

3

29

Biphasic

0.7

<1

Absent

Absent

Absent

NA

4

55

Epithelioid

4.6

11

Absent

Absent

Absent

NA

5

32

Biphasic

1.5

<1

Absent

Absent

Absent

NED at 20 yrs

6

72

Mixed

1.1

<1

Absent

Absent

Absent

NED at 2 mo

7

49

Spindle cell

0.9

1

Absent

Absent

Absent

NED at 9 yrs

8

59

Spindle cell

1.1

4

Absent

Absent

Absent

NA

9

42

Spindle cell

3.5

3

Absent

Absent

Absent

NED at 6 yrs

10

16

Spindle cell

2.5

2

Absent

Absent

Absent

NA

11

38

Epithelioid

1.1

3

Absent

Absent

Absent

NED at 1 yr

12

21

Epithelioid

9.8

64

Present

Present

Present

DOD at 3 mo

13

5

Epithelioid

2.0

5

Absent

Absent

NA

DR at 4 yrs

14

62

Spindle cell

NA

1

Absent

Absent

Absent

NED at 25 yrs

15

55

Epithelioid

1.1

1

Absent

Absent

Absent

NED at 16 yrs

16

61

Epithelioid

6.5

32

Absent

Present

Present

DOD at 6 mo

17

5

Biphasic

9.1

12

Absent

Absent

Absent

NA

18

68

Epithelioid

5.0

169

Present

Absent

Absent

MD at 9 mo

19

42

Spindle cell

0.7

1

Absent

Absent

Absent

NA

20

43

Biphasic

3.5

4

Absent

Absent

Absent

NED at 4 mo

21

69

Epithelioid

3.7

2

Present

Absent

Absent

MD at 5 mo

22

2 MO

Epithelioid

2.3

3

Absent

Absent

Absent

NA

23

54

Biphasic

3.6

11

Absent

Absent

Absent

NED at 19 mo

24

66

Epithelioid

NA

34

Absent

Present

Present

DR at 9 mo

25

39

Biphasic

3.0

7

Absent

Absent

Absent

NA

26

21

Biphasic

5.8

3

Absent

Absent

Absent

NED at 1 mo

  1. All available clinical and histologic features of the 26 cases are listed, along with any available clinical follow-up. LVI lymphovascular invasion, MO months, NA not available, HPF high-powered fields, NED no evidence of disease, DOD dead of disease, DR disease recurrence, MD metastatic disease, MO months, YRS years. 1Except case 22 (2 months old).